Percutaneous cryoablation of kidney tumors after partial nephrectomy
Introduction: The widespread use of ultrasound and cross-sectional imaging has led to a steady increase in the incidental discovery of renal masses. Most of them are treated with partial nephrectomy (PN), as recommended by the European Association of Urology guidelines. However, this approach carrie...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2024-10-01
|
| Series: | Videosurgery and Other Miniinvasive Techniques |
| Subjects: | |
| Online Access: | https://www.mp.pl/videosurgery/issue/article/17904/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832582449081614336 |
|---|---|
| author | Wojciech Krajewski Maciej Guziński Wojciech Tomczak Łukasz Nowak Jan Łaszkiewicz Joanna Chorbińska Adam Chełmoński Katarzyna Grunwald Bartosz Małkiewicz Tomasz Szydełko |
| author_facet | Wojciech Krajewski Maciej Guziński Wojciech Tomczak Łukasz Nowak Jan Łaszkiewicz Joanna Chorbińska Adam Chełmoński Katarzyna Grunwald Bartosz Małkiewicz Tomasz Szydełko |
| author_sort | Wojciech Krajewski |
| collection | DOAJ |
| description | Introduction: The widespread use of ultrasound and cross-sectional imaging has led to a steady increase in the incidental discovery of renal masses. Most of them are treated with partial nephrectomy (PN), as recommended by the European Association of Urology guidelines. However, this approach carries a risk of local recurrence. In such a case, surgical reintervention can be more challenging and is often associated with worse prognosis. In this context, percutaneous ablative therapies are a promising alternative.
Aim: This study presents our experience with using percutaneous cryoablation (PCA) to manage recurrences and new masses in previously operated kidneys.
Materials and methods: We conducted a retrospective data analysis to evaluate patients treated with PCA for tumor recurrence or residual disease in the postresection bed, excluding those with de novo or recurrent tumors in the contralateral kidney.
Results: A total of 23 individuals met the inclusion criteria. Of those, 14 initially underwent laparoscopic PN, and 9 were treated with open surgery. The median interval from the initial surgery to recurrence-targeted PCA was 23 months (range, 7–228). The mean (SD) RENAL score on admission was 7.5 (1.9), and the median (interquartile range) tumor volume was 3 (1.6–4.5) ml. The median length of hospital stay was 23 hours (range, 6–55). There was no significant change in estimated glomerular filtration rate following cryoablation. All the recorded complications, except one, were grade I and resolved with hydration or treatment with nonsteroidal anti-inflammatory drugs. No patient required dialysis in the perioperative period.
Conclusions: Imaging-guided PCA is a feasible and effective treatment option for patients with renal tumor recurrences after PN. |
| format | Article |
| id | doaj-art-628e9c1949594050b18c656a00e29fd1 |
| institution | Kabale University |
| issn | 1895-4588 2299-0054 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Videosurgery and Other Miniinvasive Techniques |
| spelling | doaj-art-628e9c1949594050b18c656a00e29fd12025-01-29T18:27:25ZengTermedia Publishing HouseVideosurgery and Other Miniinvasive Techniques1895-45882299-00542024-10-0119448348810.20452/wiitm.2024.17904Percutaneous cryoablation of kidney tumors after partial nephrectomyWojciech Krajewski0Maciej Guziński1Wojciech Tomczak2Łukasz Nowak3Jan Łaszkiewicz4Joanna Chorbińska5Adam Chełmoński6Katarzyna Grunwald7Bartosz Małkiewicz8Tomasz Szydełko9Department of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandDepartment of General Radiology, Interventional Radiology and Neuroradiology, Wroclaw Medical University, Wrocław, PolandUniversity Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandUniversity Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandUniversity Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandUniversity Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandUniversity Centre of Excellence in Urology, Wroclaw Medical University, Wrocław, PolandIntroduction: The widespread use of ultrasound and cross-sectional imaging has led to a steady increase in the incidental discovery of renal masses. Most of them are treated with partial nephrectomy (PN), as recommended by the European Association of Urology guidelines. However, this approach carries a risk of local recurrence. In such a case, surgical reintervention can be more challenging and is often associated with worse prognosis. In this context, percutaneous ablative therapies are a promising alternative. Aim: This study presents our experience with using percutaneous cryoablation (PCA) to manage recurrences and new masses in previously operated kidneys. Materials and methods: We conducted a retrospective data analysis to evaluate patients treated with PCA for tumor recurrence or residual disease in the postresection bed, excluding those with de novo or recurrent tumors in the contralateral kidney. Results: A total of 23 individuals met the inclusion criteria. Of those, 14 initially underwent laparoscopic PN, and 9 were treated with open surgery. The median interval from the initial surgery to recurrence-targeted PCA was 23 months (range, 7–228). The mean (SD) RENAL score on admission was 7.5 (1.9), and the median (interquartile range) tumor volume was 3 (1.6–4.5) ml. The median length of hospital stay was 23 hours (range, 6–55). There was no significant change in estimated glomerular filtration rate following cryoablation. All the recorded complications, except one, were grade I and resolved with hydration or treatment with nonsteroidal anti-inflammatory drugs. No patient required dialysis in the perioperative period. Conclusions: Imaging-guided PCA is a feasible and effective treatment option for patients with renal tumor recurrences after PN.https://www.mp.pl/videosurgery/issue/article/17904/ablative therapypercutaneous cryoablationrecurrencerenal cell carcinomarenal cryoablation |
| spellingShingle | Wojciech Krajewski Maciej Guziński Wojciech Tomczak Łukasz Nowak Jan Łaszkiewicz Joanna Chorbińska Adam Chełmoński Katarzyna Grunwald Bartosz Małkiewicz Tomasz Szydełko Percutaneous cryoablation of kidney tumors after partial nephrectomy Videosurgery and Other Miniinvasive Techniques ablative therapy percutaneous cryoablation recurrence renal cell carcinoma renal cryoablation |
| title | Percutaneous cryoablation of kidney tumors after partial nephrectomy |
| title_full | Percutaneous cryoablation of kidney tumors after partial nephrectomy |
| title_fullStr | Percutaneous cryoablation of kidney tumors after partial nephrectomy |
| title_full_unstemmed | Percutaneous cryoablation of kidney tumors after partial nephrectomy |
| title_short | Percutaneous cryoablation of kidney tumors after partial nephrectomy |
| title_sort | percutaneous cryoablation of kidney tumors after partial nephrectomy |
| topic | ablative therapy percutaneous cryoablation recurrence renal cell carcinoma renal cryoablation |
| url | https://www.mp.pl/videosurgery/issue/article/17904/ |
| work_keys_str_mv | AT wojciechkrajewski percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT maciejguzinski percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT wojciechtomczak percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT łukasznowak percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT janłaszkiewicz percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT joannachorbinska percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT adamchełmonski percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT katarzynagrunwald percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT bartoszmałkiewicz percutaneouscryoablationofkidneytumorsafterpartialnephrectomy AT tomaszszydełko percutaneouscryoablationofkidneytumorsafterpartialnephrectomy |